• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Omeros

plan B fail reroute road path trail miss
Biotech

FDA delays Omeros' 2nd attempt at transplant drug’s approval

After receiving more information from the biotech, the FDA informed the company that the decision date has been pushed back to Dec. 26.
James Waldron Aug 15, 2025 5:55am
Stock exchange concept

Omeros stock up after data analysis spurs BLA resubmission plan

Dec 19, 2024 10:54am
failure crash no fail rocket cancelled end

Omeros stops kidney disease phase 3 after interim review fail

Oct 16, 2023 8:45am
reins rider cowboy horse steady hands saddle

Omeros saddles up for 2nd charge at transplant drug approval

Mar 14, 2023 9:30am
clock calendar time late delayed alarm

Omeros' Hail Mary throw for blood clot med delayed at FDA

Aug 17, 2022 11:21am
FDA Building 2

FDA rejects Omeros drug over difficulties estimating its effect

Oct 18, 2021 8:15am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings